Evidence map›Paper›PMID 39134520›Full record

ArticleNature communications2024

Single-cell long-read targeted sequencing reveals transcriptional variation in ovarian cancer.

Ashley Byrne, Daniel Le, Kostianna Sereti, Hari Menon, Samir Vaidya, Neha Patel, Jessica Lund, Ana Xavier-Magalhães, Minyi Shi, Yuxin Liang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases.Computational and structural biotechnology journal · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ashley Byrne *Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.ORCID 0000-0002-2177-924X
Daniel Le *Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Kostianna SeretiDepartment of Discovery Oncology, Genentech, South San Francisco, CA, USA.
Hari MenonDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Samir VaidyaDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Neha PatelDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Jessica LundDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Ana Xavier-MagalhãesDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Minyi ShiDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Yuxin LiangDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA.
Timothy Sterne-WeilerDepartment of Discovery Oncology, Genentech, South San Francisco, CA, USA.ORCID 0000-0003-2023-0383
Zora ModrusanDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA. modrusan.zora@gene.com.
William StephensonDepartment of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA. stephenson.william@gene.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell RNA sequencing predominantly employs short-read sequencing to characterize cell types, states and dynamics; however, it is inadequate for comprehensive characterization of RNA isoforms. Long-read sequencing technologies enable single-cell RNA isoform detection but are hampered by lower throughput and unintended sequencing of artifacts. Here we develop Single-cell Targeted Isoform Long-Read Sequencing (scTaILoR-seq), a hybridization capture method which targets over a thousand genes of interest, improving the median number of on-target transcripts per cell by 29-fold. We use scTaILoR-seq to identify and quantify RNA isoforms from ovarian cancer cell lines and primary tumors, yielding 10,796 single-cell transcriptomes. Using long-read variant calling we reveal associations of expressed single nucleotide variants (SNVs) with alternative transcript structures. Phasing of SNVs across transcripts enables the measurement of allelic imbalance within distinct cell populations. Overall, scTaILoR-seq is a long-read targeted RNA sequencing method and analytical framework for exploring transcriptional variation at single-cell resolution.

Indexed as

Ovarian NeoplasmsPolymorphism, Single NucleotideSequence Analysis, RNASingle-Cell AnalysisAllelic ImbalanceCell Line, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansRNA IsoformsTranscriptomeRNA Isoforms

Identifiers

PMID39134520
PMCPMC11319652

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.